2-pro-PSA (p2PSA) |
|
1 |
2023-08-08 |
Aethanol |
Äthyl-Alkohol |
2 |
2023-11-14 |
ALAT (GPT) |
Alaninaminotransferase |
1 |
2023-06-06 |
Albumin |
|
2 |
2023-06-06 |
Aldosteron |
|
1 |
2023-06-06 |
Alk. Phosphatase (AP) |
|
1 |
2023-06-06 |
Alpha-1-Antitrypsin |
|
2 |
2023-06-06 |
Alpha-Fetoprotein |
|
2 |
2023-06-06 |
Amphetamin /U qual. |
|
1 |
2023-08-08 |
ANA |
Antinukleäre Antikörper Muster und Titer |
1 |
2023-06-06 |
ANCA Immunfluoreszenz |
Bestimmung von Auto-Antikörpern gegen c-ANCA, p-Anca und x-Anca |
1 |
2023-06-06 |
Androstendion |
|
1 |
2023-06-06 |
Antistaphylolysin |
Anti-Staphylolysin-Alpha-Hämolysin |
1 |
2023-06-06 |
APC-Resistenz (Ratio) |
Resistenz gegen aktiviertes Protein C |
3 |
2023-06-06 |
ASAT (GOT) |
Aspartataminotransferase |
2 |
2023-06-06 |
Autoimmunhepatitis-Blot |
Antikörper gegen AMA-M2, M2-3E (BPO), Sp100, PML, gp210, LKM-1, LC-1, SLA/LP und Ro-52 |
1 |
2023-06-06 |
Barbiturate /U qual. |
|
1 |
2023-06-06 |
Basophile Gr. abs. |
|
1 |
2023-06-06 |
Basophile Gr. rel. |
|
1 |
2023-06-06 |
Benzodiazepine /U qual. |
|
1 |
2023-08-08 |
Beta-Crosslaps |
|
2 |
2023-06-06 |
Beta-HCG |
Beta-humanes Choriongonadotropin |
2 |
2023-06-06 |
Beta2-Glycoprotein 1 IgG-AK |
|
1 |
2023-06-06 |
Beta2-Glycoprotein 1 IgM-AK |
|
1 |
2023-06-06 |
Bikarbonat venös |
|
1 |
2023-06-06 |
Bilirubin |
|
1 |
2023-06-06 |
Bilirubin, direktes |
|
1 |
2023-06-06 |
Borrelien-AK IgG |
|
2 |
2023-06-06 |
Borrelien-AK IgM |
|
1 |
2023-06-06 |
BUN |
Harnstoff-Stickstoff |
1 |
2023-06-06 |
C-Peptid |
|
1 |
2023-06-06 |
C3 Komplement |
|
2 |
2023-06-06 |
C4 Komplement |
|
2 |
2023-06-06 |
CA 125 |
|
1 |
2023-06-06 |
CA 19-9 |
Carbohydrate-Antigen 19-9 |
2 |
2023-06-06 |
Calcitonin |
|
2 |
2023-08-08 |
Calcium |
|
2 |
2023-06-06 |
Calcium /Sammelharn |
|
1 |
2023-06-06 |
Calcium /Spontanharn |
Calcium im Harn |
1 |
2023-06-06 |
Calprotectin / Stuhl |
|
2 |
2023-06-06 |
Cannabinoide /U qual. |
|
1 |
2023-08-08 |
Cardiolipin-AK IgG |
|
1 |
2023-06-06 |
Cardiolipin-AK IgM |
|
1 |
2023-06-06 |
CCP-AK |
Antikörper gegen cyclische citrullinierte Peptide (IgG) |
1 |
2023-06-06 |
CEA |
Karzinoembryonales Antigen |
1 |
2023-06-06 |
Chlam. tr.-AK IgA |
Chlamydia trachomatis Antikörper IgA |
1 |
2023-06-06 |
Chlam. tr.-AK IgG |
Chlamydia trachomatis Antikörper IgG |
1 |
2023-06-06 |
Chlorid |
|
2 |
2023-06-06 |
Chlorid /Sammelharn |
|
1 |
2023-06-06 |
Chlorid /Spontanharn |
|
1 |
2023-06-06 |
Cholinesterase |
|
1 |
2023-06-06 |
CK-MB |
Creatinkinase-Muscle-Brain |
1 |
2023-06-06 |
CMV-AK IgM |
Cytomegalievirus-AK IgM |
1 |
2023-06-06 |
Cocain /U qual. |
|
1 |
2023-06-06 |
Coeruloplasmin |
|
2 |
2023-06-06 |
Cortisol |
|
1 |
2023-06-06 |
Covid-2 AK IgG |
|
1 |
2023-08-08 |
CPK |
|
1 |
2023-06-06 |
CRP |
C-reaktives Protein |
1 |
2023-06-06 |
CRP (kapillär) POCT |
|
1 |
2023-08-08 |
CRP POCT |
C-reaktives Protein |
1 |
2023-06-06 |
D-Dimer |
|
2 |
2023-06-06 |
D-Dimer POCT |
|
2 |
2023-11-14 |
DHEA-S |
Dihydroepiandro-steron-Sulfat |
1 |
2023-06-06 |
Digoxin |
|
1 |
2023-06-06 |
dsDNA-AK |
Auto-Antikörper gegen doppelsträngige genomische DNA |
3 |
2023-06-06 |
EBV-AK (EBNA) IgG |
IgG-Antikörpern gegen das Kern-Antigen des Epstein-Barr-Virus (EBNA) |
1 |
2023-06-06 |
EBV-AK (VCA) IgG |
IgG-Antikörper gegen Kapsid-Antigene des Epstein-Barr-Virus (VCA) |
1 |
2023-06-06 |
EBV-AK (VCA) IgM |
IgM-Antikörpern gegen Kapsid-Antigene des Epstein-Barr-Virus (VCA) |
1 |
2023-06-06 |
Ecstasy /U qual. |
|
1 |
2023-08-08 |
Eisen |
|
1 |
2023-06-06 |
ENA Subsets |
Autoantikörper gegen extrahierbare nukleäre Antigene (ENA) |
2 |
2023-06-06 |
Eosinophile Gr. abs. |
|
1 |
2023-06-06 |
Eosinophile Gr. rel. |
|
1 |
2023-06-06 |
Erythropoetin |
|
1 |
2023-06-06 |
Erythrozyten |
|
1 |
2023-06-06 |
Faktor XIII Akt. |
|
2 |
2023-06-06 |
Fraktionelle Harnsäureexkretion |
|
1 |
2023-06-06 |
Freie Lambda Leichtkette |
|
1 |
2023-06-06 |
Freie Leichtkette, Typ Kappa |
|
1 |
2023-06-06 |
freies PSA |
|
1 |
2023-06-06 |
Freies T3 |
|
1 |
2023-06-06 |
Freies T4 |
|
1 |
2023-06-06 |
FSH |
|
1 |
2023-06-06 |
FV / FII Labgen (Gruppe) |
|
1 |
2023-06-06 |
GAD-AK |
Autoantikörper gegen Glutamat-Decarboxylase (GAD) |
1 |
2023-06-06 |
GFR/1.7m2KO (CKD-EPI) |
glomerulären Filtrationsrate nach Chronic Kidney Disease Epidemiology Collaboration-Formel |
1 |
2023-06-06 |
Gliadin-AK IgA |
Antikörper gegen Gliadin (IgA) |
2 |
2023-03-10 |
Gliadin-AK IgG |
Antikörper gegen Gliadin (IgG) |
2 |
2023-03-10 |
Glucose |
|
4 |
2023-06-06 |
Glucose (venös) POCT |
|
2 |
2023-11-14 |
Glucose /Sammelharn |
|
1 |
2023-06-06 |
Glucose /Spontanharn |
|
1 |
2023-06-06 |
H2 Atemtest Fruktose |
Fruktosetoleranztest |
1 |
2023-06-06 |
H2 Atemtest Laktose |
Laktosetoleranztest |
1 |
2023-06-06 |
H2 Atemtest Sorbit |
Sorbittoleranztest |
1 |
2023-06-06 |
Hämatokrit |
|
1 |
2023-06-06 |
Hämoglobin |
|
1 |
2023-06-06 |
Hämoglobin A1c (%) |
|
1 |
2023-08-08 |
Haptoglobin |
|
1 |
2023-06-06 |
Harnsäure |
|
1 |
2023-06-06 |
Harnsäure /Sammelharn |
|
1 |
2023-06-06 |
Harnsäure /Spontanharn |
|
1 |
2023-06-06 |
Harnstoff-N /Spontanharn |
|
1 |
2023-06-06 |
HAV-AK |
Hepatitis A Gesamt AK / HAV-Antikörper quant. |
1 |
2023-06-06 |
HAV-AK IgM |
Hepatitis A -AK IgM |
1 |
2023-06-06 |
Hb-Äquivalent der Retikulozyten |
|
1 |
2023-06-06 |
Hb-Elektrophorese |
|
1 |
2023-06-06 |
HBV c-AK |
Hepatitis B-Virus c-AK |
1 |
2023-06-06 |
HBV c-AK IgM |
Hepatitis B-Virus c-AK IgM |
1 |
2023-06-06 |
HBV e-AG |
Hepatitis-B-e-Antigen |
2 |
2023-06-06 |
HBV e-AK |
Anti-HBe-Antikörper |
2 |
2023-06-06 |
HBV s-AG |
Hepatitis B-Virus s-AG |
1 |
2023-06-06 |
HBV s-AK |
Hepatitis B-Virus s-AK |
1 |
2023-06-06 |
HCV-AK |
Hepatitis C-AK |
2 |
2023-06-06 |
Helicob. pylori-AG /ST |
|
1 |
2023-06-06 |
Helicob. pylori-AK IgG |
|
1 |
2023-06-06 |
HFE Labgen (Gruppe) |
|
1 |
2023-06-06 |
HLA-B27 Labgen (Gruppe) |
|
1 |
2023-06-06 |
hochsensitives Troponin I |
|
1 |
2023-06-06 |
Humane Anti-Maus-AK (HAMA) |
|
1 |
2023-08-08 |
humanes Luteinisierendes Hormon |
|
1 |
2023-06-06 |
IA2-AK |
Autoantikörper gegen Tyrosin-Phosphatase (IA2) |
1 |
2023-06-06 |
IgE |
Immunglobulin E |
3 |
2023-08-08 |
IgG1 |
|
1 |
2023-06-06 |
IgG2 |
|
1 |
2023-06-06 |
IgG3 |
|
1 |
2023-06-06 |
IgG4 |
|
1 |
2023-06-06 |
Immunfixation |
|
1 |
2023-06-06 |
Immunfixation /U |
|
1 |
2023-06-06 |
Immuntypisierung |
|
1 |
2023-06-06 |
Inhalationsallergene |
Antikörper gegen Inhalationsantigene (g1, g3, g6, g12, t2, t3, t4, t7, w1, w6, w9, d1, d2, e1, e2, e3, m1, m2, m3, m6, CCD) |
1 |
2023-06-06 |
Inhalationsallergene Bäume |
Antikörper gegen Inhalationsantigene t1, t2, t3, t4, t5, t7, t15, t12, t14, t16, CCD |
1 |
2023-06-06 |
INR (PTZ) |
International Normalized Ratio (Prothrombinzeit) |
2 |
2023-08-08 |
Insektengifte |
Antikörper gegen Insektengifte i1, i3, i75, i208, i213, i216, i209, i211, CCD |
1 |
2023-06-06 |
Insulin |
|
1 |
2023-06-06 |
IPF |
Unreife Thrombozytenfraktion |
1 |
2023-06-06 |
Kalium |
|
2 |
2023-06-06 |
Kalium /Sammelharn |
|
1 |
2023-06-06 |
Kalium /Spontanharn |
|
1 |
2023-06-06 |
Kalium POCT |
|
2 |
2023-11-14 |
Kreatinin POCT |
|
2 |
2023-11-14 |
Laktat |
|
1 |
2023-06-06 |
LDH |
Lactate Dehydrogenase |
1 |
2023-06-06 |
Legionella pn.-AG /U |
Legionella pneumophilia |
1 |
2023-06-06 |
Leukozyten |
|
1 |
2023-06-06 |
Lipase |
|
1 |
2023-06-06 |
Lipoprotein (a) |
|
1 |
2023-06-06 |
Lithium |
|
1 |
2023-06-06 |
LMW-Heparin (anti-FXa Akt.) |
|
3 |
2023-02-14 |
Lues Bestätigung IgG Blot |
Anti-Treponema pallidum-EUROLINE-WB (IgG) |
1 |
2023-06-06 |
Lues Bestätigung IgM Blot |
Anti-Treponema pallidum-EUROLINE-WB (IgM) |
1 |
2023-06-06 |
Lupusantikoagulans |
|
3 |
2023-02-14 |
Lymphozyten abs. |
|
2 |
2023-11-14 |
Lymphozyten rel. |
|
2 |
2023-11-14 |
Magnesium |
|
1 |
2023-06-06 |
Magnesium /Sammelharn |
|
1 |
2023-06-06 |
Magnesium /Spontanharn |
|
1 |
2023-06-06 |
MCH |
Mittlerer Hämoglobingehalt pro Erythrozyt |
1 |
2023-06-06 |
MCHC |
Mittlere korpuskuläre Hämoglobin-Konzentration |
1 |
2023-06-06 |
MCV |
Mittleres Erythrozyteneinzelvolumen |
1 |
2023-06-06 |
Metamphetamine /U qual. |
|
1 |
2023-08-08 |
Methadon /U qual. |
|
1 |
2023-08-08 |
Mittleres Plättchenvolumen MPV |
|
1 |
2023-06-06 |
Mononukleose-Schnelltest |
|
2 |
2023-03-10 |
Monozyten abs. |
|
1 |
2023-06-06 |
MPO-AK |
IgG Antikörper gegen Myeloperoxidase |
1 |
2023-06-06 |
Myoglobin |
|
1 |
2023-06-06 |
Myositis-Blot |
Antikörper gegen Mi-2ß, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ und Ro-52 |
1 |
2023-06-06 |
Nahrungsmittelallergene |
Antikörper gegen Nahrungsmittelallergene f1, f75, f2, f78, f4, f5, f14, f10, f13, f256, f17, f20, f49, f95, f25, f31, f35, f85, f3, f24, CCD |
1 |
2023-06-06 |
Natrium |
|
1 |
2023-06-06 |
Neutrophile Gr. abs. |
|
1 |
2023-06-06 |
Neutrophile Gran. rel. |
|
1 |
2023-06-06 |
Normoblasten (NRBC) |
|
1 |
2023-06-06 |
Normoblasten (NRBC) rel. |
|
1 |
2023-06-06 |
Oestradiol |
Sensitives Oestradiol |
1 |
2023-06-06 |
Opiate /U qual. |
|
1 |
2023-06-06 |
Osteocalcin |
|
1 |
2023-06-06 |
Oxycodon /U qual. |
|
1 |
2023-08-08 |
P-LCR |
Anteil großzelliger Plättchen |
1 |
2023-06-06 |
Pankreas-Amylase |
|
1 |
2023-06-06 |
Pankreas-Amylase /Spontanharn |
|
1 |
2023-06-06 |
PDW |
Plättchen-Verteilungsbreite |
1 |
2023-06-06 |
Phencyclidin /U qual. |
|
1 |
2023-08-08 |
Phosphat |
|
1 |
2023-06-06 |
Phosphat /Sammelharn |
|
1 |
2023-06-06 |
Phosphat /Spontanharn |
|
1 |
2023-06-06 |
PKT |
Plättchenkrit |
1 |
2023-06-06 |
Plasmodien-AG |
|
1 |
2023-06-06 |
Pollen |
Antikörper gegen Inhalationsantigene t3, g6, t215, t216, t220, t225, g205, g215, g210, g212, CCD |
1 |
2023-06-06 |
PR3-AK |
Antikörper gegen Proteinase 3 (IgG) |
1 |
2023-06-06 |
Procalcitonin |
|
2 |
2023-06-06 |
Progesteron |
|
1 |
2023-06-06 |
Prolaktin |
|
1 |
2023-06-06 |
Prostata Health Index (phi) |
|
1 |
2023-08-08 |
Protein C Aktivität |
|
2 |
2023-06-06 |
Protein S AG, freies |
|
3 |
2023-02-14 |
PTH intakt (intraoperativ) |
intraoperatives Parathormon |
1 |
2023-06-06 |
PTZ (Prothrombinzeit) |
|
2 |
2023-06-06 |
Quantiferon-Test |
|
1 |
2023-06-06 |
RDW-CV |
Erythrozyten-Verteilungsbreite |
1 |
2023-06-06 |
Renin |
Direct Renin |
1 |
2023-06-06 |
Reti, hohe Fluoreszenzrate |
|
1 |
2023-06-06 |
Reti, mittlere Fluoreszenzrate |
|
1 |
2023-06-06 |
Reti, niedrige Fluoreszenzrate |
|
1 |
2023-06-06 |
Retikulozyten abs. |
|
1 |
2023-06-06 |
Retikulozyten rel. |
|
1 |
2023-06-06 |
Rheumafaktor |
|
1 |
2023-06-06 |
Rötelnvirus-AK IgG qn. |
|
1 |
2023-06-06 |
Rötelnvirus-AK IgM ql. |
|
1 |
2023-06-06 |
Sars-CoV-2-PCR / Abstrich |
|
2 |
2023-08-03 |
Schwangerschaftstest /U |
|
1 |
2023-06-06 |
SHBG |
|
1 |
2023-06-06 |
Sklerodermie-Blot |
Antikörper gegen Scl-70, CENP A, CENP B, RP11, RP155, Fibrillarin, NOR90, Th/To, PM-Scl100, PM-Scl75, Ku, PDGFR, Ro-52 |
1 |
2023-06-06 |
SMA (ASMA) Titer IF |
Bestimmung von Auto-Antikörpern gegen glatte Muskulatur mittels Immunfluoreszenz |
2 |
2023-06-06 |
Streptococcus pn.-AG /U |
Streptococcus pneumoniae |
1 |
2023-06-06 |
Stuhl auf Blut |
|
1 |
2023-06-06 |
Testosteron |
|
1 |
2023-06-06 |
Testosteron, bioverf. (calc.) |
Berechneter Parameter aus Testosteron, SHBG und Albumin |
2 |
2023-06-06 |
Testosteron, bioverf. (calc.) % |
|
1 |
2023-06-06 |
Testosteron, freies (calc.) |
|
1 |
2023-06-06 |
Testosteron, freies (calc.) % |
|
1 |
2023-06-06 |
Thrombozyten |
|
1 |
2023-06-06 |
Thyreoglobulin |
|
1 |
2023-06-06 |
Thyreoglobulin-AK |
|
1 |
2023-06-06 |
Tierallergene |
Antikörper gegen Inhalationsantigene e1, e2, e3, e6, e71, e73, e82, e84, es7, es172, CCD |
1 |
2023-06-06 |
Totalprotein |
|
1 |
2023-06-06 |
Totalprotein /Sammelharn |
|
1 |
2023-06-06 |
Totalprotein /Spontanharn |
|
1 |
2023-06-06 |
Toxoplasma gondii-AK IgG qn. |
Toxo IgG II |
1 |
2023-06-06 |
Toxoplasma gondii-AK IgM ql. |
Toxo IgM |
1 |
2023-06-06 |
TPO-AK |
Thyreoperoxidase- AK |
1 |
2023-06-06 |
Transferrin |
|
1 |
2023-06-06 |
Trizykl. Antidepressiv /U qual. |
|
1 |
2023-08-08 |
Troponin I POCT |
hs-cTnI |
1 |
2023-03-23 |
Tryptase |
|
1 |
2023-06-06 |
TSH |
Thyreoidea-stimulierendes Hormon Thyreotropin |
1 |
2023-06-06 |
TSH-Rezeptor-AK |
Autoantikörper gegen Thyreotropin (TSH)-Rezeptor (TRAK) |
1 |
2023-06-06 |
tTGA IgA |
Antikörper gegen Gewebs-Transglutaminase (IgA) |
1 |
2023-06-06 |
Unreife Retikulozytenfraktion |
|
1 |
2023-06-06 |
Unreife Thrombozytenfraktion |
|
1 |
2023-06-06 |
Vancomycin |
|
2 |
2023-06-06 |
VDRL (RPR)-Titer |
RPR reditest |
1 |
2023-08-08 |
VSM47 |
Anti-F-Actin-IIFT |
1 |
2023-08-08 |